Loading candles…
Incorporated in 1984, Panacea Biotec Ltd is a research-driven company operating in the biotechnology, pharmaceuticals, and health management industries. It focuses on the development, manufacturing, and marketing of vaccines, pharmaceutical formulations, and nutrition products. The company leverages R&D-led innovation and maintains cGMP-compliant manufacturing facilities, which are qualified by global regulatory authorities including the US FDA, WHO PQ, and EMA. Panacea Biotec holds a leading position in the Indian vaccine market and exports its products to more than 50 countries worldwide. With over 30 years of operational history, it integrates biotechnology and health management through its product offerings, serving primarily the Indian market and a broad international footprint.
| Details |
|---|
| Date |
|---|
| Results - FY26 | PANACEABIO : 30-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 29, 2026 has been re-scheduled. Further, the Company… | 30 May 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 11 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 14 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and passing over of dividend on equity as well as preference shares for the… | 30 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.